DanCann Pharma A/S: Publishes Q1-2024 Report
COPENHAGEN, Denmark, 01 June 2024 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the "Company"), a Danish company powered by cannabinoids, hereby announce that the Company has published its report for the first quarter of 2024 (“Q1-2024”). The Q1-2024 report is available as an attached document to this press release and at www.dancann.com.Summary: Group Key Figures Q1-2024 DKK 1,000 01/01/24 01/01/23 01/01/23 – 31/12/23 01/01/22 – 31/12/22 –31/03/24 –31/03/23 Net sales: 702 620 6,073 5,708 Operating -2,645 -4,